The QualityStocks Daily Monday, April 29th, 2019

Today's Top 3 Investment Newsletters

MarketClub Analysis (PRPO) +1,475.00%

StockMarketWatch (EMES) +56.28%

QualityStocks (INLB) +22.22%

The QualityStocks Daily Stock List

Predictive Technology Group, Inc. (PRED)

NetworkNewsWire, Zacks, OTC Markets, Insider Tracking, Market Screener, Proactive Investors, InvestorsHub, Insider Financial, StreetWise Reports, pm360, Equity Clock, Wallet Investor, Investors Hangout, Business Insider, 4-Traders, Simply Wall St, Stockhouse, Wallmine, Infront Analytics, and Dividend Investor reported earlier on Predictive Technology Group, Inc. (PRED), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Predictive Technology Group, Inc. is a leader in the use of data analytics for disease identification and subsequent therapeutic intervention via precision therapeutic treatments. The Company's goal is to revolutionize patient care through predictive data analytics, novel gene-based diagnostics and companion therapeutics through its subsidiaries Predictive Therapeutics, Predictive Biotech, and Predictive Laboratories. Predictive Technology Group lists on the OTC Markets and is headquartered in Salt Lake City, Utah.

The Company's subsidiaries concentrate on endometriosis, scoliosis, degenerative disc disease and human cell and tissue products. These subsidiaries use genetic and other information as cornerstones in the development of new diagnostics, which assess a person's risk of illness and therapeutic products designed to identify, prevent and treat diseases more effectively.

Further to the Company's efforts to advance regenerative medicine, it is committed to assisting women in overcoming the devastating consequences of endometriosis through appropriate early-stage diagnosis and subsequent treatment. Predictive Biotech, Inc., a Salt Lake City life sciences company is a leader in human cell and tissue products for use in regenerative medicine. A growing national network of clinics, health systems, researchers and physicians take advantage of Predictive's four main placental-derived and Wharton's jelly umbilical cord-derived products.

Predictive Laboratories centers on clinical and discovery work for human infertility and genetic conditions affecting women and children. This includes endometriosis, scoliosis and degenerative disc disease. Testing is performed using state-of-the-art instrumentation at its CAP and CLIA accredited facility.

In March, Predictive Technology announced it completed the acquisition of Taueret Laboratories, LLC, a clinical and research molecular laboratory, for $9,747,800, with $1,200,000 paid at closing in the form of Predictive Technology Group's restricted common stock and $8,547,800 to be paid on or before December 31, 2020, subject to certain conditions. Taueret Laboratories will join Predictive Technology Group's newest subsidiary Predictive Laboratories.

Additionally, in March, Predictive Technology Group announced it completed the buildout of a new production laboratory and research and Development (R&D) facility for its subsidiary company, Predictive Biotech. The newly renovated 22,000 square foot facility, located in Research Park on the University of Utah's campus, features an ISO 7 cleanroom and 18 ISO 5 production hoods.

Last week, Predictive Technology Group announced that Ms. Christine Seward, MS, CGC, joined Predictive Laboratories as Senior Vice President of Sales and Marketing. Ms. Seward brings wide-ranging experience commercializing molecular diagnostics. This includes products in the reproductive space from her 16-year tenure at Myriad Genetics.

Predictive Technology Group, Inc. (PRED), closed Monday's trading session at $2.59, up 12.85%, on 536,065 volume with 599 trades. The average volume for the last 3 months is 217,303 and the stock's 52-week low/high is $0.769/$3.077.

chart

Item 9 Labs Corp. (INLB)

Invest Tribune, CannabisMarketCap, Pot Stock News, Tip Ranks, Market Screener, Financial Content, Stockhouse, Wallet Investor, GlobeNewswire, Financial Buzz, Investors Hangout, Trading View, Dividend Investor, GuruFocus, Equity Clock, Business Insider, InvestorsHub, OTC Markets, and Stockwatch reported earlier on Item 9 Labs Corp. (INLB), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Item 9 Labs Corp. is a leader in comfortable cannabis health solutions for the contemporary consumer. It is bringing best of industry practices to markets across the nation via cultivation and production, distinctive retail environments, licensing services, and varied product suites. The Company caters to different medical cannabis demographics. Item 9 Labs has its head office in Phoenix, Arizona. In addition, it has medical cannabis operations in numerous U.S. markets.

Item 9 Labs' asset portfolio includes Dispensary Permits, Dispensary Templates, and Strive Life. Dispensary Permits is its consulting firm. It specializes in strategic license application and compliance. Dispensary Templates, a subdivision of the firm, is a technology platform with a wide-ranging digital library of licensing and business planning resources.

Strive Life is a turnkey dispensary model for the retail sector. It improves the patient experience with consistent and first-rate service, high-end design, and precision-tested products. At present, it is undergoing implementation in Arizona and North Dakota.

Moreover, Item 9 Labs has created complementary brands - Item 9 Labs and Strive Wellness - to channel consumer diversity. Propriety delivery platforms include the Apollo Vape and Pod system, and also a ground-breaking intra-nasal device. Item 9 Labs has received manifold accolades for its medical-grade flower and concentrates. The Company will be managing cultivation, processing, distribution, and dispensary operations in up to ten U.S. markets by the end of this year. Present facilities include distribution and processing operations - Strive Wellness of Ohio and Strive Wellness of Nevada, and a dispensary - Strive Life North Dakota.

Last month, Item 9 Labs announced that Chief Executive Officer Sara Gullickson and African-American Advisory Board Members Donald Burton and Larry K. Lemons were awarded a processor provisional license for Strive Wellness of Ohio, LLC. The entity qualified as a disadvantaged group because of its minority-led ownership team. Strive Wellness of Ohio was acknowledged as one of the top scoring applicants in the very competitive licensing process. The Medical Marijuana Control Program at the Ohio Department of Commerce received 104 processor applications for 40 licenses.

This month, Item 9 Labs announced it launched construction of Strive Wellness of Nevada. This is a medical cannabis cultivation and processing facility. It has distribution rights in Pahrump, Nevada. In June of 2018, Item 9 Labs became an operating partner of Strive Wellness of Nevada. The new cultivation and production space encompasses 20,000 square-feet. This doubles the overall square-footage of the Company's existing aggregate facilities.

Item 9 Labs corporate plans for 2019 include market share in six to ten U.S. cannabis markets by the end of the year. Corporate plans also include identifying and pursuing the acquisition of up to four cannabis facilities in existing legal cannabis markets.

Moreover, plans include operating, activating, and/or expanding existing Company cannabis facilities in Arizona, Nevada, as well as North Dakota. Plans additionally included completing the 20,000 square-foot construction of the Strive Wellness of Nevada processing facility in Q4 and continuing expansion of Item 9 Labs' distribution and sales network.

Item 9 Labs Corp. (INLB), closed Monday's trading session at $5.50, up 22.22%, on 28,663 volume with 84 trades. The average volume for the last 3 months is 2,103 and the stock's 52-week low/high is $1.50/$8.39.

chart

PharmaCielo Ltd. (PHCEF)

Small Cap Power, Stock Twits, Stocks News Feed, Stockhouse, PR Newswire, Trading View, Stock Target Advisor, Baystreet, New Cannabis Ventures, Market Screener, InvestorsHub, National Institute for Cannabis Investors, and Technical420 reported on PharmaCielo Ltd. (PHCEF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

PharmaCielo Ltd. is the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis oil, PharmaCielo Colombia Holdings S.A.S. PharmaCielo is an international company with an emphasis on ethical and sustainable processing and supplying of all natural, medicinal-grade cannabis oil extracts and related products to large channel distributors. The Company lists on the OTC Markets and is based in Toronto, Ontario.

PharmaCielo's principal, and wholly-owned subsidiary, PharmaCielo Colombia Holdings S.A.S., is headquartered at its nursery and propagation center in Rionegro, Colombia. PharmaCielo is the first company to hold Colombian licences for cannabis with unrestricted percentages of tetrahydrocannabinol (THC) and cannabidiol (CBD). This makes the Company the the world's largest licensed producer (LP).

The Company states that its medicinal-grade oil extracts and related products provide reliable, standardized relief and wellness formulas for patients in need. This includes those requiring higher levels of THC.

PharmaCielo's facility features 12.1 hectares (1.3 million square feet) of open-air greenhouses ready for cultivation. It will supply plant seedlings to greater than 1,000 hectares (2,500 acres) of contract growers' open-air greenhouses for final cultivation. PharmaCielo is working on the construction and commercial commissioning of a downstream processing facility. Its objective is to commence commercial sales in the first half of this year.

Recently, PharmaCielo announced that its Colombian subsidiary received from the national cultivar registry approval for the listing of a further 10 strains. Each has a prominent tetrahydrocannabinol (THC) profile. The additional registration of the new strains to the national cultivar registry, including an innovative 1:1 THC to CBD ratio strain, doubles the number of approved strains PharmaCielo holds in the registry. This makes it the largest holder of approved strains in Colombia. Additionally, it paves the way for the commercial registration, production and sale of the 20 unique strains.

On January 28, 2019, PharmaCielo announced that it had established an equity joint venture (JV) with Mino Labs S.A. de C.V, a specialty pharmaceutical company and medical supply distributor headquartered in Mexico, to bring medicinal cannabis oil to Mexico. In addition, on March 19, 2019, PharmaCielo received ISO 9001 Quality Assurance Certification for its medicinal cannabis cultivation and processing operations in Colombia.

On April 9, 2019, PharmaCielo appointed a Medical and Scientific Advisory Board consisting of a global panel of renowned physicians, researchers, veterinarians, engineers and academics. The advisory board will guide the Company's research and development (R&D) of special cannabinoids-based formulations and derived products with therapeutic properties.

PharmaCielo Ltd. (PHCEF), closed Monday's trading session at $6.4777, up 6.02%, on 145,891 volume with 339 trades. The average volume for the last 3 months is 53,502 and the stock's 52-week low/high is $4.75/$9.98.

chart

Chemesis International, Inc. (CADMF)

Green Stock Report, Insider Financial, CannabisMarketCap, CannabisFN, OTC Markets, InvestorsHub, Tip Ranks, Market Screener, Stockhouse, Marketbeat, Small Caps Daily, The Trading Letter, Financial Buzz, Midas Letter, Business Insider, Trading View, GlobeNewswire, Technical420, Investing News, Canadian Insider, Dividend Investor, Insider Tracking, and Stockwatch reported beforehand on Chemesis International, Inc. (CADMF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Presently operating within California, Puerto Rico, and Colombia, Chemesis International, Inc. is a vertically integrated worldwide leader in the cannabis industry. The Company is developing a strong presence in important markets. This is from cultivation, to manufacturing, distribution and retail. Chemesis International lists on the OTC Markets Group's OTCQB. The Company is headquartered in Vancouver, British Columbia.

Chemesis International has facilities in Puerto Rico and California, allowing for the cost effective production and distribution of its products. Furthermore, the Company takes advantage of exclusive brands and partnerships. In addition, it uses the highest quality extraction methods to provide consumers with quality cannabis products.

With it's global reach and exclusive partnerships, Chemesis International is working to establish and grow new markets around the world. The Company has current operations underway in Puerto Rico with Natural Ventures, in Colombia with La Finca, and in California with California Sap and Desert Zen.

Chemesis has its state-of-the-art grow facility in Puerto Rico that highlights a 2,000-plus grow light capacity and a 30,000-plus lb overall grow capacity. Moreover, La Finca brings greater than 1,000 acres of land for cultivation in Colombia. Chemesis has more than 2,000 relationships with farming families that comprise its land package.

Pertaining to Manufacturing, Chemesis International is able to offer it's clients all kinds of extractions, formulations and products, specializing in BHO Extraction, Alchohol Extraction, and CO2 Extraction. At present, it has the capacity to process more than 2,000 lbs of raw material daily.

Regarding Distribution, Chemesis' Desert Zen currently has a considerable presence in Southern California. The Company has a fleet of fully compliant vehicles that are servicing the State.

Concerning Retail Sales, Chemesis International is currently retailing exclusive products in Puerto Rico and engaging retail storefronts in the California market. The Company is also working to open exclusively branded shops in numerous markets. It distributes and transports California Sap, Jay and Silent Bob's Private Stash, and 3rd party brands to greater than 600 dispensaries in California and Puerto Rico.

Today, Chemesis International announced it began the process to expand its operations into the Central U.S. It will focus on establishing operations in Michigan, Wisconsin, Missouri, and Illinois. The Company is in the application stage in each State. Furthermore, it is in the process of completing due diligence on assets, which include cultivation, extraction, as well as distribution.

Chemesis International, Inc. (CADMF), closed Monday's trading session at $1.5615, up 4.80%, on 254,384 volume with 291 trades. The average volume for the last 3 months is 230,951 and the stock's 52-week low/high is $0.20/$1.72.

chart

Crexendo, Inc. (CXDO)

NetworkNewsWire, InvestorVillage, Simply Wall St, Tip Ranks, Zacks, Stockhouse, Seeking Alpha, Barchart, YCharts, Market Screener, Capital Cube, InvestorsHub, Stockwatch, MarketWatch, Last10k, Wallmine, 4-Traders, Marketbeat, and Wallet Investor reported previously on Crexendo, Inc. (CXDO), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Crexendo, Inc. is an award-winning first-class provider of cloud communications, UCaaS (Unified Communications as a Service), call center, collaboration services for businesses, and other cloud business services. The design of these is to provide enterprise-class cloud services to any size business at affordable monthly rates. Crexendo's shares trade on the OTC Markets' OTCQX. The Company is based in Tempe, Arizona.

Crexendo is a full-service cloud communications provider. It delivers critical voice and data communication services to small, medium, and small enterprise markets. The Company is PCI and HIPPA compliant. Crexendo is also a registered CLEC licensed for its cloud, telecommunications and network family of services.

Crexendo solutions include phones, mobile, cloud and call center. In addition, its solutions include collaboration, integrations, unified communications, as well as features. Key features for enhancing business communications and productivity include business dashboard, call recording, cloud communicator, SMS & Chat, and the aforementioned collaboration. Key features also include cloud fax, unified messaging, and also full feature suites.

In March, Crexendo reported financial results for its Q4 and full year ended December 31, 2018. Consolidated Total Revenue for Q4 2018 rose 10 percent to $3.1 million versus $2.8 million for Q4 2017. On a GAAP basis, the Company reported an $(8,000) Net Loss for Q4 2018, or breakeven per diluted common share, versus Net Income of $32,000 or breakeven per diluted common share for Q4 2017.

Consolidated Total Revenue for the year ended December 31, 2018 rose 17 percent to $11.9 million versus $10.2 million for the year ended December 31, 2017. On a GAAP basis, Crexendo reported a $(223,000) Net Loss for the year ended December 31, 2018, or $(0.02) loss per diluted common share, versus a Net Loss of $(929,000) or $(0.07) loss per diluted common share for the year ended December 31, 2017.

Crexendo will hold its Q1 2019 financial results conference call on Tuesday, April 30, 2019 at 5:30 PM EST. Mr. Steven G. Mihaylo, Chief Executive Officer, Mr. Doug Gaylor, President and Chief Operating Officer, and Mr. Ron Vincent, Chief Financial Officer, will deliver prepared remarks and conduct a question and answer session.

Crexendo, Inc. (CXDO), closed Monday's trading session at $3.05, up 3.39%, on 14,840 volume with 24 trades. The average volume for the last 3 months is 1,401 and the stock's 52-week low/high is $1.50/$3.00.

chart

Leagold Mining Corporation (LMCNF)

StreetWise Reports, Stockhouse, OTC Markets, Northern Miner, Baystreet, NewstoWatch, Ceo.ca, Metals News, InvestorsHub, 4-Traders, and StockInvest.us reported earlier on Leagold Mining Corporation (LMCNF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Leagold Mining Corporation is a mid-tier gold producer listed on the OTC Markets Group's OTCQX. It concentrates on opportunities in Latin America. The Company previously went by the name HTI Ventures Corp. It changed its name to Leagold Mining Corporation in August of 2016. Leagold Mining has its corporate office in Vancouver, British Columbia.

The Company owns four operating gold mines in Mexico and Brazil. It also has an expansion opportunity in Mexico and a near-term gold mine restart project in Brazil. Leagold Mining has an inventory of 7.1 million ounces of gold reserves from which to grow. Its operating mines are Los Filos, RDM, Fazenda, and Pilar. The Company's development projects are the Los Filos expansion and Santa Luz.

The expectation is that Leagold Mining's four gold mines in Mexico and Brazil will collectively produce 380,000-420,000 oz gold this year at an all-in sustaining cost (AISC) of $920-970/oz. In 2018, the Company produced 302,550 oz gold – in line with guidance of 295,000- 305,000 oz.

Last month, Leagold Mining announced that it filed the report entitled "Independent Technical Report for the Los Filos Mine Complex, Mexico " that presents the results of the Expansion Feasibility Study under its profile on SEDAR at www.sedar.com. The Expansion Feasibility Study was prepared by independent consultants.

The Expansion Feasibility Study incorporates the potential for development of the Bermejal underground mine, enlarging the Los Filos open pit, re-phasing of the Bermejal open pit into two distinct sections (Bermejal and Guadalupe), and building a carbon-in-leach (CIL) processing facility to complement the existing heap leach facilities. A highlight of the Expansion Feasibility Study is gold production of 3.2 million ounces (Moz) over a 10-year mine life (2019 to 2028) at an average AISC of $740/oz.

Additionally, in March, Leagold Mining reported Q4 and full year 2018 financial and operating results with consolidated gold production in 2018 of 302,550 ounces (oz) at an AISC of $974 per oz sold and resulting in an AISC margin of $83.2 million. The results produced full-year earnings from mine operations of $58.3 million and Net Income of $15.3 million. The Company's 2018 results include the Brazilian operations on a post-acquisition basis from May 24 to year end.

In early April, Leagold Mining reported Q1 2019 consolidated gold production of 105,949 ounces (oz). The results establish a strong start toward meeting full-year 2019 production guidance of 380,000 to 420,000 oz. Financial results and more production details for Q1 2019 will be reported on May 7, 2019, after the close of markets. A conference call and live webcast will follow on May 8, 2019, at 8am PDT/11am EDT.

Leagold Mining Corporation (LMCNF), closed Monday's trading session at $1.1412, down 2.46%, on 38,569 volume with 38 trades. The average volume for the last 3 months is 64,016 and the stock's 52-week low/high is $0.95/$2.63.

chart

Pacific Health Care Organization, Inc. (PFHO)

NetworkNewsWire, Infront Analytics, Dividata, Journal Transcript, Whale Wisdom, Market Exclusive, Open Insider, Zacks, 4-Traders, GlobeNewswire, Simply Wall St, Wallet Investor, Stockopedia, Investors Hangout, Capital Cube, GuruFocus, Last10k, Trading View, Dividend Investor, Research Pool, Market Screener, Stockhouse, Marketbeat, Teletrader, and InvestorsHub reported earlier on Pacific Health Care Organization, Inc. (PFHO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Pacific Health Care Organization, Inc. specializes in workers' compensation cost containment. Its business goal is to deliver value to its clients that decreases their workers' compensation related medical claims expense in a way that will assure that injured employees receive high quality healthcare, which allows them to recover from injury and return to gainful employment without undue delay. The Company's shares trade on the OTC Markets Group's OTCQB. Incorporated in 1970, Pacific Health Care Organization is headquartered in Newport Beach, California.

By way of its wholly-owned subsidiaries, Pacific Health Care Organization provides a spectrum of effective workers' compensation cost containment services. These include, but are not limited to, Health Care Organizations, Medical Provider Networks, HCO + MPN, Workers' Compensation Carve-Outs, Utilization Review, Medical Bill Review, Nurse Case Management, Lien Representation, Legal Support and Medicare Set-Aside services.

The Company's subsidiaries include Medex Healthcare, Medex Managed Care, Medex Medical Management, Medex Legal Support, and IRC (Industrial Resolutions Coalition). Via its two HCOs, Pacific Health Care Organization offers injured workers a choice of enrolling in an HCO with a network managed by primary care providers requiring a referral to specialists; or a second HCO, where injured workers do not need any beforehand authorization to be seen and treated by specialists.

Last month, Pacific Health Care Organization filed with the Securities and Exchange Commission its annual report on Form 10-K announcing financial results for the fiscal year ended December 31, 2018. It reported Total Revenue of $6,796,913 for the year ended December 31, 2018, in comparison to $6,505,527, of Total Revenue for the year ended December 31, 2017. It reported Net Income of $1,359,777 or $0.42 per basic and fully diluted share for the year ended December 31, 2018, versus Net Income of $964,405 or $0.30 per basic and fully diluted share for the year ended December 31, 2017.

Pacific Health Care Organization, Inc. (PFHO), closed Monday's trading session at $5.50, up 1.85%, on 300 volume with 1 trade. The average volume for the last 3 months is 562 and the stock's 52-week low/high is $2.75/$5.95.

chart

Bonterra Resources, Inc. (BONXF)

Investing News, Streetwise Reports, Proactive Investors, Wallet Investor, Research Pool, YCharts, Canadian Insider, Stockhouse, Mining Capital, OTC Markets, Capital Cube, The Prospector News, Investors Hangout, Mining and Energy, Junior Mining Network, InvestorsHub, and Barchart reported previously on Bonterra Resources, Inc. (BONXF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Bonterra Resources, Inc. engages in the acquisition, exploration, and evaluation of mineral properties in Canada. The Company has a large balanced portfolio of exploration and mining assets. These include the Gladiator, Barry and Moroy deposits, Urban-Barry Mill and multiple highly prospective exploration prospects. Bonterra Resources lists on the OTC Markets' OTCQX. The Company has a strong shareholder base that includes Wexford Capital, Kirkland Lake Gold, and Eric Sprott. Bonterra Resources is headquartered in Val-d'Or, Quebec.

Presently, Bonterra is developing three high-grade gold deposits: the Gladiator, Barry and Moroy projects in the mining-friendly jurisdiction of Quebec. There are significant regional targets in the Urban Barry Camp. The Company is in the process of upgrading its wholly-owned gold mill to boost capacity from 800 to 2400 tpd. In addition, a property-wide mineral resource estimate is taking place and will include the Gladiator, Barry and Moroy deposits. Bonterra Resources controls the only permitted gold mill in the region with a large land position of roughly 20,815 hectares in the Urban Barry Camp.

Earlier this month, Bonterra Resources announced assay results from its continuing diamond drilling program at its Gladiator Project positioned in the Urban Barry exploration camp in northern Quebec. The results reported extend a number of the gold-bearing mineralized zones along strike on the Gladiator Deposit.

Regarding the Barbeau zone, current drilling has extended the zone by 250 meters, confirming its continuity in grade and length with hole BA-19-24, which returned 14.6 g/t Au over 4.6 m. The Barbeau zone has now been outlined over a strike length of 450 meters to a depth of 200 meters.

The Rivage 2 zone is positioned north of the Gladiator deposit. Initially discovered by field prospecting in the summer of 2018, the mineralized zone now extends more than 350 meters to a depth of 200 meters. Drill hole BA-19-28 returned 37.6 g/t Au over 1.7 m. The Rivage 2 zone remains open along strike and at depth.

The South zone is in the heart of the Gladiator deposit. It was intersected in drill hole BA-19-26A, which returned 17.7 g/t Au over 2.0 m. Mineralization usually comprises smoky quartz, pyrite, sphalerite and visible gold. Attesting to Bonterra Resources' geological modeling and continuity of the mineralized zones, this drill hole was expected to intersect the South zone before reaching the Barbeau zone.

Bonterra Resources, Inc. (BONXF), closed Monday's trading session at $1.288, up 2.22%, on 2,525 volume with 4 trades. The average volume for the last 3 months is 18,220 and the stock's 52-week low/high is $0.223/$2.87.

chart

Aerogrow International, Inc. (AERO)

Stockpools, Stock Twits, Stockhouse, Daily Marijuana Observer, Equity Clock, Last10k, Zacks, Seeking Alpha, 4-Traders, Simply Wall St, Marketwired, MarketWatch, Infront Analytics, Wallet Investor, InvestorsHub, New Cannabis Ventures, Marketbeat, and Market Screener reported previously on Aerogrow International, Inc. (AERO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Aerogrow International, Inc. engages in the development, marketing, direct-selling, and wholesale of indoor garden systems to consumers and retailers in the U.S., Canada, and various countries in Europe. The Company is the manufacturer and distributor of AeroGardens - the world's leading family of In-Home Garden Systems™. Aerogrow International lists on the OTC Markets Group's OTCQB. Established in 2002, the Company is headquartered in Boulder, Colorado.

Aerogrow International has its AeroGarden line of Smart Countertop Gardens. The Miracle-Gro AeroGarden line is sold via numerous channels. These include on-line retail sales through .com retailers; in-store retail sales; as well as direct-to-consumer sales using an array of digital, social and print media to boost sales at www.aerogarden.com. Aerogrow's products are used in the gardening, cooking, healthy eating, and home and office décor markets.

All of the Company's Miracle-Gro AeroGardens are smart gardens. They feature proprietary technology that helps consumers to grow fresh herbs, vegetables and more indoors, year round, with no dirt, no weeds and no expertise needed.

Miracle-Gro AeroGardens are complete indoor gardening systems. They have built in, full spectrum Grow Lights that turn on and off automatically, and reminders that tell one when to add water and the patented liquid nutrients. All AeroGardens come with a Gourmet Herb Seed Kit. In addition, more than 50 other seed kits are available.

Aerogrow International's main products include indoor gardens and proprietary seed pod kits. These allow consumers to grow vegetables, such as tomatoes, chili peppers, and salad greens; fresh herbs consisting of cilantro, chives, basil, dill, oregano, and mint; and flowers, which consist of petunias, snapdragons, geraniums, and vinca. Additionally, the Company provides grow lights and a patented nutrient formula, and also assorted cooking, gardening, and decor accessories.

The basis of Aerogrow International's distribution strategy continues to be utilizing Amazon and on-line sales via its retail partners. This part of its business has continued to show strong growth.

Aerogrow International, Inc. (AERO), closed Monday's trading session at $1.48, up 3.50%, on 6,447 volume with 19 trades. The average volume for the last 3 months is 12,880 and the stock's 52-week low/high is $1.22/$3.40.

chart

TILT Holdings, Inc. (SVVTF)

Stock Gumshoe, Micro Small Cap, Stock Target Advisor, Market Screener, Midas Letter, The Seed Investor, Insider Financial, Stockwatch, Street Insider, Trading View, Dividend Investor, OTC Markets, Investors Hangout, New Cannabis Ventures, MarketWatch, InvestorsHub, and Stockhouse reported beforehand on TILT Holdings, Inc. (SVVTF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, TILT Holdings, Inc. is a foremost provider of products and services to businesses operating in the cannabis industry. It offers the contract manufacturing of marijuana in an array of form factors, vaporizer and inhalation devices, business and consumer delivery services and a wide collection of software products for more than 1,500 retailers and brands throughout the United States, Canada and Europe. TILT Holdings has its corporate office in Cambridge, Massachusetts. It also has offices throughout the U.S., Toronto and London.

Essentially a vertically-integrated technology and infrastructure cannabis company, TILT's vision is to provide value to all cannabis retailers via software, infrastructure, access to capital, and more. The Company offers wide-ranging operations and software solutions at each point in the supply chain. This is from vertically-integrated operations to innovative genetics and business technology solutions.

TILT's intention is to broaden its capabilities via a pipeline of infrastructure expansions, acquisitions and partnerships. Its aim is to deliver the highest quality products and services where laws permit.

TILT is organized in two primary business units - Software & Services and Consumer Devices & Packaged Goods. The design of these is to augment competencies across the organization in research, manufacturing, packaging and technology to deliver end-to-end services and customer solutions.

Last week, TILT Holdings announced that its wholly-owned subsidiary, Baker Technologies, Inc., closed a loan to Standard Farms Ohio LLC for up to US$3,000,000. This will enable the companies to work together in the fast growing Ohio medical marijuana market.

Standard Farms is building a state-of-the-art 10,000 sq. ft. processing facility in Garfield Heights. It will utilize technologies and Standard Operating Procedures based on current Good Manufacturing Practices. At present, Standard Farms holds a provisional processor permit for the Facility that it anticipates being operational in late 2019, subject to, among other things, the receipt of a certificate of operation from the State of Ohio Department of Commerce.

Mr. Alex Coleman, Chairman and Chief Executive Officer of TILT Holdings, said, "Ohio is a large and rapidly growing cannabis market and we look forward to increasing our exposure to the Buckeye state through this relationship."

Today, TILT Holdings announced that Jupiter Research, LLC, a leader in inhalation and vaporization technology and a wholly-owned subsidiary of TILT, has further expanded distribution of its proprietary, high-performance technologies in California via its integration with TILT's software and supply chain services. This expansion permits Jupiter to establish a physical presence with increased geographic reach throughout California. This enables TILT to develop stronger customer relationships and deliver Jupiter products to B2B customers faster than before. TILT acquired Jupiter early this year to further expand its technology ecosystem and B2B reach across the supply chain.

TILT Holdings, Inc. (SVVTF), closed Monday's trading session at $2.06, up 3.00%, on 663,982 volume with 743 trades. The average volume for the last 3 months is 314,949 and the stock's 52-week low/high is $0.2835/$3.00.

chart

Tofutti Brands, Inc. (TOFB)

Zacks, Simply Wall St, 4-Traders, Financial Content, Stockhouse, Stock Invest, Wallet Investor, Market Screener, Dividend Investor, Marketbeat, Capital Cube, and InvestorsHub reported earlier on Tofutti Brands, Inc. (TOFB), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Tofutti Brands, Inc. develops and distributes a complete line of plant-based products. It sells greater than 35 milk-free foods. These include cheese products, frozen desserts, as well as prepared frozen dishes. The Company's products are available throughout the U.S. and in over 30 countries. Tofutti Brands answers the call of millions of people who are allergic or intolerant to dairy, diabetic, kosher or vegan, and also those who desire to have a healthier low-fat diet. OTCQB-listed and founded in 1981, Tofutti Brands is headquartered in Cranford, New Jersey.

The Company's product line includes plant-based ice cream pints, cones, Tofutti Cutie® sandwiches and novelty bars. In addition, Tofutti sells a prepared food entrée, Mintz's Blintzes®, made with Tofutti's milk-free cheeses such as Better Than Cream Cheese® and Sour Supreme®.

All of the Company's products are certified Kosher Parve. This means that none of its products ever contain any dairy whatsoever. This means no milk by-products either, such as casein, whey, skim milk powder, or dairy lactic acid. Tofutti Brands sells its products via independent unaffiliated food brokers to distributors, and on a direct basis to retail chain accounts or to warehouse accounts that directly service chain accounts.

Recently, Tofutti Brands issued its results for the Fiscal Year (FY) ended December 29, 2018. It reported Net Income of $507,000 ($0.10 per share) on Net Sales of $13,066,000 for the FY ended December 29, 2018, versus Net Income of $704,000 ($0.14 per share) on Net Sales of $14,107,000 for the FY ended December 30, 2017.

Sales of vegan cheese products decreased to $10,811,000 in fiscal 2018 from $11,237,000 in fiscal 2017. Sales of the Company's frozen dessert and frozen food product lines decreased to $2,255,000 in fiscal 2018 from $2,870,000 in fiscal 2017.

Mr. David Mintz, the Chairman and Chief Executive Officer of Tofutti Brands, said, "Despite a number of events that impacted the sales of our Better Than Cream Cheese, Sour Supreme and frozen dessert products, we were able to report net income of $507,000 in fiscal 2018. We believe that these issues are substantially behind us. We plan to introduce our new Dippity Do Dah Cheese Dips and reintroduce our Tofutti MarryMe Bars, Chocolate Fudge Treats, and Totally Fudge Pops in the second quarter of 2019 in time for the summer season and look forward to a better 2019."

Tofutti Brands, Inc. (TOFB), closed Monday's trading session at $1.75, up 2.94%, on 2,622 volume with 5 trades. The average volume for the last 3 months is 1,687 and the stock's 52-week low/high is $1.45/$3.17.

chart

ForeverGreen Worldwide Corporation (FVRG)

Hotstocked, MicroCapDaily, The Street, Seeking Alpha, Penny Stock Hub, Penny Stock Tweets, Uptick Newswire, Infront Analytics, Investor Place, OTC Markets, InvestorsHub, 4-Traders, MarketWatch, Stockopedia, YCharts, Simply Wall St, Wallet Investor, GuruFocus, and Barchart reported earlier on ForeverGreen Worldwide Corporation (FVRG), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

ForeverGreen Worldwide Corporation is an international direct marketing business and provider of health and wellness products. The Company develops, manufactures, and distributes a comprehensive line of all-natural whole foods and products to North America,  Australia,  Europe,  Asia, and South America. ForeverGreen Worldwide is based in Lindon, Utah.

ForeverGreen's products include its global Xpress offering Prodigy-5™, featuring the exclusive TransArmor™ Nutrient Technology. Moreover, its products include PowerStrips™, SolarStrips™, with industry exclusive marine phytoplankton, and BeautyStrips™.

Prodigy-5 is an all-in-one nutritional shot. It features the patent-pending and exclusive TransArmor™ Nutrient Technology for increased absorption. Prodigy-5 provides vitamins, minerals, antioxidants and energy, all in one. The TransAmor™ Nutrient Technology is patent pending. TransAmor™ Nutrient Technology allows the nutrients in formulated products to be significantly better absorbed by the body.

Additionally, the Company has its KetonX product. KetonX is a drink product that allows the body to begin converting into a state of nutritional ketosis within a matter of hours. It features a patented blend of ingredients.

ForeverGreen Worldwide also offers the North American market its weight-management line Ketopia™, as well as additional weight management products. The Company also offers its Pulse-8™ powered L-arginine formula for cardiovascular health. Also, ForeverGreen has its new wearable technology called CareWear™.

ForeverGreen Worldwide is formulating a line of products, specifically using CBD for human wellness. It has previously incorporated CBD in past products. The Company believes the new products will initially be available in the European Markets.

In February, ForeverGreen Worldwide announced it is preparing for its first product launch and expansion into the CBD market.

Mr. Joe Jensen, the Company's Executive Officer, said, "We are particularly eager to expand our company products into the CBD industry. This is such a rapidly, growing market right now and we anticipate these CBD products are going to drive sales worldwide. The buzz for CBD hemp oil has been steadily increasing and goes along with our overall goal, to promote health and wellness. Capturing a small part of this booming industry is going to bring endless opportunities for ForeverGreen."

Beginning late Q1, five new products featuring CBD oil are to be phased in and completed over the course of this year. ForeverGreen continues its emphasis on the CBD industry and ketogenic products.

ForeverGreen Worldwide Corporation (FVRG), closed Monday's trading session at $0.11, up 2.80%, on 24,325 volume with 6 trades. The average volume for the last 3 months is 37,490 and the stock's 52-week low/high is $0.0235/$0.389.

chart

International Stem Cell Corp. (ISCO)

Tip.us, MissionIR, Serious Traders, Tiny Gems, BioCentury, Market Screener, Stock Invest, Marketbeat, Barchart, GuruFocus, Equity Clock, Research Gate, Canadian Insider, StocksToBuyNow, Zacks, Morningstar, and MarketWatch reported beforehand on International Stem Cell Corp. (ISCO), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

International Stem Cell Corp. is a clinical stage biotechnology company listed on the OTC Markets' OTCQX. It is developing stem cell-based therapies and biomedical products. The Company's emphasis is on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. International Stem Cell has a research facility in Oceanside, California. The Company is based in Carlsbad, California.

International Stem Cell scientists have created the first parthenogenetic, homozygous stem cell line. The Company produces and markets specialized cells and growth media for therapeutic research globally via its subsidiary Lifeline Cell Technology and stem cell-based skin care products via its subsidiary Lifeline Skin Care.

International Stem Cell's core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs). The hpSCs avoid ethical issues associated with the use or destruction of viable human embryos. They offer the potential to create the first true stem cell bank, UniStemCell™. The UniStemCell™ bank is the life science industry's first collection of non-embryonic histocompatible human stem cells available for research and commercial use. The human leukocyte antigen (HLA) system represents antigens crucial for transplantation.

This past January, International Stem Cell announced that the United States Patent and Trademark Office (USPTO) granted the Company US Patent No. 10,172,890 on the topical use of lysate from human parthenogenetic (non-embryonic) stem cells to visibly improve signs of skin aging. The patented stem cell lysate is encapsulated and delivered from protective liposomes. It is combined with antioxidants, vitamins and peptides to provide skin benefits including decreasing the depth/number of facial fine lines and wrinkles, increasing skin elasticity/firmness, and improving skin hydration.

Last month, International Stem Cell announced that the results of its preclinical studies in traumatic brain injury (TBI) were published in Theranostics, a prestigious peer-reviewed medical journal. The publication, titled, "Human parthenogenetic neural stem cell grafts promote multiple regenerative processes in a traumatic brain injury model," demonstrated that the clinical-grade neural stem cells used in the Company's Parkinson's disease clinical trial, ISC-hpNSC®, considerably improve TBI-associated motor, neurological, and cognitive deficits without any safety issues. The paper is available on International Stem Cell's website.

International Stem Cell Corp. (ISCO), closed Monday's trading session at $1.20, up 7.14%, on 7,810 volume with 16 trades. The average volume for the last 3 months is 6,824 and the stock's 52-week low/high is $1.03/$1.89.

chart

Stem Holdings, Inc. (STMH)

Jet Life Penny Stocks, Wallet Investor, MarketWatch, Stockopedia, Barchart, 4-Traders, Stockhouse, GuruFocus, Simply Wall St, Dividend Investor, Investors Hangout, InvestorsHub, OTC Markets, last10k, Morningstar, Trading View, YCharts, Market Screener, and Midas Letter reported earlier on Stem Holdings, Inc. (STMH), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Stem Holdings, Inc. develops strategic brands for modern-day cannabis consumers. It builds and partners with companies in manifold sectors of the marijuana market from distribution to hemp cultivation. The Company purchases, improves, and leases properties for use in the cannabis production, distribution, and sales industry in the Oregon. OTCQB-listed, Stem Holdings is based in Boca Raton, Florida.

Stem Holdings' brands and partnerships comprise Incredibles; Reefer Distribution Co.; Supernatural; Cannavore, and PUL. Moreover, the Company's brands and partnerships include TJ's Gardens; GreenTFarms; Travis x James; Dose-Ology; G Pen, and Craft Extracts.

Pertaining to the Company's Cultivation & Processing Properties, it has its 42nd Street facility. This large warehouse serves as a premier indoor cultivation facility just outside of Eugene, Oregon. The property has 22 grow rooms.

Regarding Stem Retail Properties, the Company builds boutique retail stores. TJ's Provisions is its flagship marijuana dispensary, located in Eugene, Oregon. Also, Stem has its TJ's on Willamette marijuana dispensary about one mile from the University of Oregon campus. Additionally, the Company has its TJ's on Powell. This is a 2,000 square foot retail storefront in Portland, Oregon.

Stem also has its Mulino Farm greenhouse cultivation facility. This property in Clackamas County has 12 commercial-grade greenhouses. Stem also has its Applegate Farms cultivation facility that consists of 40 acres in Jacksonville, Oregon.

The Company also has its TJ's Wallis. This Eugene property will include two facilities. They will provide space for cultivation and processing. This location has a first-rate commercial kitchen for edibles production and grow rooms and an extraction lab. The Company's TJ's Las Vegas property (5,450 square feet) outside of Vegas will allow cultivation, processing, and distribution operations for the fast-growing Nevada cannabis market.

Last week, Stem Holdings announced that its facility, TJ's on Powell, received a license and final approval from the Oregon Liquor Control Commission to operate its newest dispensary location in Portland, Oregon. The new dispensary is located on Powell Boulevard. The Portland destination will feature an in-house coffee shop. It will serve hemp derived CBD coffee and tea to neighborhood patrons and daily commuters.

This week, Stem Holdings announced it executed a definitive agreement dated March 22, 2019 to acquire South African Ventures, Inc. (SAV). SAV has a joint venture (JV) with Profile Solutions, Inc. (PSIQ). The JV received preliminary approval to become the only licensed growing farm and processing plant for medical cannabis and industrial hemp in The Kingdom of eSwatini f/k/a Swaziland for a minimum of 10 years.

Mr. Adam Berk, Stem Holdings' Chief Executive Officer, stated "We are very excited to expand our cannabis and industrial hemp operations globally through our partnership with The Kingdom of eSwatini. Products produced at the eSwatini Facility will initially be available for export to countries including but not limited to Australia and the European Union." 

Stem Holdings, Inc. (STMH), closed Monday's trading session at $1.91, up 0.53%, on 10,114 volume with 10 trades. The average volume for the last 3 months is 12,239 and the stock's 52-week low/high is $1.319/$7.75.

chart

The QualityStocks Company Corner

Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P)

The QualityStocks Daily Newsletter would like to spotlight Nabis Holdings (OTC: INNPF).

Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P), dba Innovative Properties Inc., is a Canadian investment company pursuing interests in high-quality cash-flow assets in real property, securities, cryptocurrency and all branches of the cannabis sector. The company's focus on strategic revenue generation, EBITDA and growth is enshrined in its moto, "One team. One goal," and is reflected in its name: "Na bis," which is defined as, "repeat performance" or "encore."

Strategy

While the Nabis' targets span numerous industries, the company aims to establish an Anchor Investment Portfolio primarily through the acquisition of majority interests in high quality U.S. cannabis assets and brands that have achieved cash flow. The company will then employ a hands-on approach to assist the investee in implementing standards and consistency to enhance their operations.

Criteria for investment targets are as follows:

  • Positive EBITDA, vertically integrated operators in limited license states with large addressable markets
  • Emphasis on operations that add material EBITDA within 12 months with enhanced access to capital and Nabis' value add approach on operations and brand consistency
  • Identifying proven operators with good expertise to add value to a consolidation strategy
  • Focused on MSOs (Multi-state Operators) with strong brand traction
  • Pharma grade cultivation, extraction, dispensaries and other addressable operations

Current Endeavors

Nabis has completed investments in five Michigan properties with Cannabis provisioning, processing and cultivation licenses. The Company has also entered into binding Letters of Intent ("LOI") to invest in vertically integrated assets in Michigan, Arizona and Washington State. The company's goal is to be invested in four to five additional states in the coming months.

Arizona – LOI to acquire full control of Organica Patient Group Inc. ("OPG") and RDF Management Group. OPG is a fully integrated medical marijuana business licensed under the provisions of the Arizona Medical Marijuana Act. Its assets include the Chino Valley MMJ Dispensary and fully established Patient Group, which since 2012 has operated as "Organica Patient Group" in Chino Valley. OPG also operates a 26,000-square-foot indoor cultivation and processing center along with a 56,600-square-foot greenhouse in Prescott Valley; has its own branded products and wholesale operations which includes distribution to more than 25% of the dispensaries in Arizona; and has exclusive manufacturing and licensing agreements with Fire Brand, Gas Extracts and Donuts Concentrate products distributed within Arizona.

Michigan – LOIs to invest in multiple strategically located properties that have or are eligible for municipal approvals for provisioning centers in Michigan. The company is currently evaluating 10 to 15 additional municipally approved locations in Michigan that would substantially increase the company's overall presence in the U.S. cannabis space.

Washington State – LOI to purchase assets from PDT Technologies LLC, including extraction and production equipment and rights to lease the current production facility in Port Townsend, Wash. The LOI includes licensing rights to produce Chong's Choice Brand CO2 Vape Cartridges, one of the leading and most recognizable brands in the cannabis space. Expansion plans include construction of a new ISO designed extraction clean room and GMP lab facility with new, highly specialized equipment with two extraction lines. The facility could produce up to 20,500 kg of cannabis concentrate on an annual basis.

Hivemind Refinery – LOI to invest in a 70% interest of Hivemind Refinery, an established line of CBD-based wellness products in the United States. The investment into Hivemind expands Nabis' investment portfolio to CBD edibles, water, drops, lotions, and other CBD wellness products across the spectrum. Nabis anticipates Hivemind will be a premium consumer CBD line to be distributed across the U.S. and Canada and will focus on products utilizing locally grown, premium CBD along with unique formulations and delivery systems.

Bloombox – binding term sheet with Momentum Ideas Co. to acquire certain assets used and marketed under the brand "Bloombox," a leading intelligent retail cannabis software platform that includes the Bloombox Software and data platform. The acquisition of Bloombox will create a dominating presence in the U.S. cannabis market, featuring an integrated ecosystem of modern, next-generation cannabis technology. Bloombox is one of the world's first standards-based cannabis software systems, enabling frictionless integration with nearly any business system or regulatory body.

Proven Management Team

CEO and Director Shay Shnet has over 20 years of experience in business and was most recently a founding partner and vice president of operations of MPX Bioceutical (CSE: MPX). While at MPX, Shnet focused on the North American cannabis space and helped build the company's portfolio of international cannabis assets. He is highly skilled in finding unique opportunities and has been directly involved with the development, branding, importing, consumer packaging and distribution of a wide variety of product lines.

President Mark Krytiuk is a very successful cannabis operator and was a founding partner of MPX. As the vice president of grow operations of MPX, he oversaw the production of medical marijuana and pharma-grade products across North America. He has been directly involved in overseeing the rapid expansion and buildout of nine facilities in three countries with budgets ranging up to $30 million. Krytiuk's experience includes consulting and working with customers to develop individual requirements for indoor and outdoor cannabis cultivation while working with federal regulators and licensing bodies to ensure compliance.

Nabis Holdings (OTC: INNPF), closed the day's trading session at $0.44, off by 1.79%, on 109,969 volume with 82 trades. The average volume for the last 3 months is 556,616 and the stock's 52-week low/high is $0.416/$0.791.

Recent News

chart

Kontrol Energy Corp. (CSE: KNR) (OTC: KNRLF) (FSE: 1K8)

The QualityStocks Daily Newsletter would like to spotlight Kontrol Energy Corp. (CSE: KNR).

Kontrol Energy Corp. (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8), a leader in the energy-efficiency sector, is working to reshape the way consumers use, manage and strategically allocate resources. The company has taken root in myriad industries and promises to help customers realize their energy-efficiency goals. NOTE TO INVESTORS: The latest news and updates relating to KNRLF are available in the company's newsroom at http://nnw.fm/KNRLF.

Kontrol Energy Corp. (CSE: KNR) (OTC: KNRLF) (FSE: 1K8) specializes in the integration of smart energy technologies and solutions for North American commercial and industrial property owners and operators to help them benefit from energy cost savings and minimize greenhouse gas emissions. Kontrol is a leader in the energy efficiency sector through IoT, Cloud and SaaS technology and is ranked by Canadian Business and Maclean’s as the 7th fastest growing startup in 2018.

Kontrol’s leadership position is reshaping the way customers use, manage and strategically allocate energy resources to realize immediate energy savings by gaining more control over energy consumption and demand in real-time.

As the fastest growing global “fuel source,” energy efficiency is big business with industry analysts noting this multi-trillion-dollar market offers significant opportunities over the next five years. Established market segments include: energy retrofits ($71.4 billion); distributed generation ($179.9 billion); energy analytics ($33.5 billion); and greenhouse gas/carbon measurement, reduction ($1.2 trillion). Each $1 invested in energy efficiency displaces up to $3 of utility-scale transmission and distribution investment, according to the International Energy Agency.

Formed in 2015 by a group of energy veterans who recognized that the energy efficiency industry is one of the fastest growing fuel sources for the global economy, Kontrol is committed to enhancing and improving its customers sustainability objectives. In less than two years, Kontrol has grown its revenue run rate to $16 million from $1.8 million, delivering on stated goals and objectives as it seeks to continue this pattern through accretive acquisitions and the expansion of the company’s smart energy technologies.

Up to 50 percent of Kontrol’s overall revenues are recurring annually, and the company’s 2019 outlook includes strategic initiatives that will expand the company’s smart energy technologies to U.S. markets, bring additional accretive and strategic acquisitions, and accelerate recurring SaaS revenues.

Kontrol’s strategy of disciplined mergers and acquisitions includes the following highlights:

  • Acquisition of Log-One Ltd.’s award-winning energy conservation technology, Energy Management System (“EMS”), an intelligent, occupancy-based heating and air-conditioning control system for commercial and multi-residential real estate. Rebranded as Kontrol EMS Technology, the company has added IoT and mobile application capabilities, creating a recurring revenue platform through a Software-as-a-Service (SaaS) platform.
  • Acquisition of ORTECH Consulting Inc., an engineering consulting firm specializing in Greenhouse Gas (GHG) reporting, emission testing, air quality testing and renewable energy/power consulting.
  • Acquisition of Efficiency Engineering Inc. (“EE Inc.”), which provides engineering services to industrial, municipal and commercial building owners across Canada. EE Inc. provides detailed energy efficiency analysis, energy audits, management of facility system solutions, electrical and mechanical design and energy conservation studies.
  • Acquisition of MCW Dimax Ltd. (“MCX”), a firm specializing in solutions for the application of energy software to analyze the management of complex heating, ventilation and cooling systems for large residential, commercial, and mission critical real estate owners.
  • Acquisition of CEM Specialties Inc. (“CEMSI”), a market leader in turn-key emission monitoring, equipment and solutions.

The company has also established entry into the North American cannabis market as a supplier of integrated energy efficiency solutions and technologies. Within this market, Kontrol is focused on assisting cannabis growers to reduce the cost of energy and support mission critical infrastructures. To date, Kontrol has secured two contracts to provide energy efficiency services with Licensed Producers in the Canadian cannabis sector.

The Kontrol Energy group of companies is currently saving its customers more than 40 million kilowatt hours of electricity per annum and providing a corresponding reduction in GHG emissions.

Kontrol’s management team includes CEO Paul Ghezzi, a leader in clean tech, renewable energy development, solar project financing and distributed generation. Ghezzi has global experience in power generation projects under Feed-in Tariff programs and Power Purchase Agreement programs for both commercial and utility-scale projects. COO Kristian Lavereau has more than 25 years of experience in the IT solutions (analytics and mobile computing), energy optimization and efficiency (intelligent control systems, solar PV, lighting). Claudio Del Vasto, CPA, CA | CFO, is a senior finance executive with an extensive background in corporate finance, strategy and business development.

Kontrol Energy Corp. (CSE: KNR), closed the day's trading session at $0.82, up 5.13%, on 43,717 volume with 19 trades. The average volume for the last 3 months is 38,142 and the stock's 52-week low/high is $0.46/$0.99.

Recent News

chart

Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G)

The QualityStocks Daily Newsletter would like to spotlight Sproutly Canada, Inc. (SRUTF).

Sproutly Canada Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G) foresees a lucrative vertical emerging in the cannabis sector as the cannabinoid-infused beverages and edibles space continues to grow in popularity with consumers. A report from cannabis market research firm ArcView Research and BDS Analytics projects rapid growth in this arena, with sales of cannabis-derived edibles, which include beverages, expected to surpass $4 billion in the U.S. and Canada by 2022 (http://nnw.fm/oRd8j). NOTE TO INVESTORS: The latest news and updates relating to SRUTF are available in the company's newsroom at http://nnw.fm/SRUTF.

Sproutly Canada, Inc. (OTCQB: SRUTF) (TSX.V: SPR) (FRA: 38G) is developing and bringing to market cannabis consumer products with a focus on beverages. The company’s core mission is to become the leading supplier of water-soluble cannabis solutions and bio-natural oils for brands in the emerging cannabis beverage and edibles market.

To make this happen, Sproutly acquired Infusion Biosciences to bring to market a patent-pending Aqueous Phytorecovery Process (APP) technology, a fundamental paradigm shift within the cannabis industry. Replacing traditional water-compatible solutions with true natural water solubility improves the body’s ability to utilize cannabinoids, making the effect of the cannabis almost immediate.

This revolutionary process doesn’t alter the cannabis compounds and provides an onset time and offset time that mimics the same effects as inhaled marijuana. That means consumers may feel effects in five minutes or less and be free from the desired effect in approximately 90 minutes—a vastly different ingestion pattern than current methods. In addition, the water-based cannabinoids can be mixed with other liquids and stay dissolved in those liquids. The application of water-soluble cannabis infusions has potential to be widespread in both medicinal and recreational cannabis sectors, giving Sproutly a distinctive edge in a market with untapped potential.

Sproutly’s business model is focused on processing rather than cultivating, which means its success is not constrained to growing its own cannabis. The company does own a Toronto-based, ACMPR-licensed facility designed and built with a focus on cultivating pharmaceutical-grade cannabis to produce and formulate the first natural, truly water-soluble cannabis solution. Its water-soluble ingredients and bio-natural oils will deliver revolutionary brands to international markets that are searching for well-defined commercial products.

Sproutly’s entrance in the cannabis market is perfectly timed as cannabis is moving towards mainstream acceptance. Potential users are, however, interested in consuming cannabis products as drinks and using it as oils rather than smoking. The potential cannabis beverage market is staggering, and with Sproutly owning the exclusive rights to APP technology in Canada, Australia, Jamaica, Israel and the entire European Union, the company is looking at significant international expansion opportunities.

Sproutly plans to capitalize on these international opportunities by executing on partnerships with local and globally established consumer brands to leverage their existing customer bases, expand brand loyalty, and assist with marketing and support distribution networks to deliver scientific breakthroughs with speed and efficiency?worldwide.

Management

Sproutly believes that talent drives growth. The company is committed to bringing together the best and brightest minds in the cannabis space to help with their mission to disrupt the global beverage and consumables market.

President, CEO and Director Keith Dolo recently served for more than 13 years with Robert Half, an S&P 500, NYSE-listed company. At Robert Half, Dolo held the position of vice president for more than eight years, as well as other senior roles in both operations and sales. He also sits on an advisory committee and a board position for two nonprofits in Vancouver, BC.

Chief Science Officer and Director Dr. Arup Sent has more than 35 years of experience in research and executive management at biotechnology and pharmaceutical companies. He was awarded a PhD in biochemistry from Princeton University and is a former faculty member at the National Cancer Institute and Scripps Research Institute. Sen is the inventor on five U.S. patents and numerous international patents and patent-pending applications.

Chief Financial Officer Craig Loverock is a chartered professional accountant with over 20 years of experience in accounting and finance roles in Canada, the United States and the United Kingdom. He has extensive expertise in public company reporting and transactional experience, having served as the senior financial advisor to the chairman at Magna International and acting as chief compliance officer and CFO for a private equity firm.

Head Grower Frank Han has over 12 years of experience in the horticulture industry. A previous master grower in a large commercial facility, Han has impressive expertise in all growing methods, techniques and procedures. He brings with him a wealth of knowledge in cloning, nutrient and overall plant management. Han will be in charge of the production team at Sproutly’s Toronto Herbal Remedies facility.

Sproutly Canada, Inc. (OTCQB: SRUTF), closed the day's trading session at $0.69, up 2.37%, on 696,234 volume with 339 trades. The average volume for the last 3 months is 612,175 and the stock's 52-week low/high is $0.189/$1.875.

Recent News

chart

Nightfood Holdings, Inc. (OTCQB: NGTF)

The QualityStocks Daily Newsletter would like to spotlight Nightfood Holdings, Inc. (NGTF).

Nightfood Holdings Inc. (OTCQB: NGTF), the innovative company solving America's $50 billion nighttime snacking problem, this morning announced that the Meijer supermarket chain has added Nightfood ice cream to 13 additional store locations spanning Ohio, Michigan and Illinois. To view the full press release, visit http://nnw.fm/NB9j8.

Nightfood Holdings, Inc. (OTCQB: NGTF), a pioneering consumer goods brand development company headquartered in Tarrytown, New York, owns Nightfood, Inc., creator of delicious, award-winning and better-for-you ice cream formulated by sleep and nutrition experts, and its wholly owned subsidiary MJ Munchies, Inc., which seeks to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. Known as “The Nighttime Snack Company,” Nightfood Inc. is focused on improving the late-night snacking choices of consumers while solving America’s $50 billion-dollar nighttime snacking problem.

Nightfood Ice Cream

Nightfood’s higher-protein and sleep-friendly ice cream won the 2019 Product of the Year Award in a survey of over 40,000 consumers. The annual Product of the Year survey, the world’s largest consumer-voted award for product innovation, is conducted by Kantar, a global leader in consumer research. In beating out the other finalists, consumers indicated that Nightfood’s one-of-a-kind innovation and unique value proposition made it a clear-cut winner in the ice cream space and a brand they were highly motivated to try. Winners of the 32-year-old award have been shown to outperform category sales performance by over 38 percent.

Less than two months since manufacturing their first pint of ice cream, Nightfood has now secured distribution in more than 13 states, and has received extensive media coverage from outlets such as USA Today, Fox Business’ Mornings With Maria, Parents Magazine, The Food Network, MarketWatch, The Washington Post, Business Insider, Bustle, and more.

With the Product of the Year award and millions in media coverage, Management has publicly stated their goal of securing nationwide distribution in over 10,000 retail outlets by March 31, 2020.

Formulated by leading sleep and nutrition experts, including America’s most prominent sleep expert, Dr. Michael Breus, Nightfood’s higher protein/higher fiber, and lower sugar ice cream delivers great ice cream taste and texture, while minimizing sleep-disruptive ingredients such as caffeine, excess sugar, and excess fat and calories. The addition of certain minerals, enzymes and amino acids, which research suggests can support sleep quality, is another bonus. Nightfood only uses hormone-free milk, is certified Kosher, and offers eight original flavors, five of which are gluten-free. Nightfood ice cream also uses all-natural sweeteners with no Erythritol, no sucralose, or other artificial sweeteners.

More than 37,000 consumers across the country have already requested coupons for the company’s newly launched Nightfood ice cream by entering a giveaway hosted at NightfoodIceCream.com which includes a chance to win a one-year supply (96 pints) plus a freezer for storage. The coupon program is being run in conjunction with PromotionPod, which has previously conducted successful campaigns for brands such as Chobani, Halo Top, and BodyArmor.

Nightfood Inc. began its nationwide rollout of Nightfood ice cream in February 2019, successfully securing placement in Meijer supermarket locations in the Midwest with a concentration around the metropolitan areas of Chicago, Detroit, Indianapolis, Columbus and Milwaukee. A distribution agreement with New England Ice Cream Corporation (NEIC) will also place Nightfood ice cream in outlets located throughout Massachusetts, Vermont, New Hampshire, Maine, Rhode Island and Connecticut.

Ice cream lovers in northern California will find Nightfood Ice Cream at various upscale, independent retail outlets in and around the San Francisco bay area serviced through a distribution agreement with Wonder Ice Cream Company, which services thousands of retail outlets from Bakersfield north to the Oregon border. Consumers can also purchase Nightfood ice cream online at BuyNightfood.com through the Company’s partnership with IceCreamSource.com.

Ice cream is now the 2nd most popular night snack choice, with almost half of all consumers reaching for ice cream after dark. According to IRI Worldwide, 44 percent of all snack consumption occurs between dinner and bedtime, representing a consumer spend of over $1 billion weekly on nighttime snacks in the U.S. alone. Market research giant Mintel recently released a report identifying nighttime specific food and beverages as one of their most “compelling and category changing” trends for 2017 and beyond.

Nightfood has developed a dynamic infographic resource that clearly illustrates the size and scope of the largely untapped nighttime snack category (http://NightSnacking.com). Americans everywhere are likely to identify with the infographic’s results that vividly illustrate late night snacking by age group, popular snack choice, and amount of money spent each week on feeding after-hour snack attacks. Available in eight delicious flavors, Nightfood ice cream can help consumers satisfy nighttime cravings in a better, healthier, more sleep-friendly way.

MJ Munchies, Inc.

MJ Munchies, Inc., was formed in 2018 as a new, wholly owned subsidiary of Nightfood Holdings, Inc. to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company intends to market some of these new products under the trademarked brand name “Half-Baked” and has entered into a Letter of Intent that allows Global Consortium Inc. (OTC: GCGX) subsidiary Infused Edibles to receive an exclusive license to manufacture and distribute marijuana and CBD-infused products under the Half-Baked brand.

Management believes the Half-Baked brand will give the Company a unique and defensible competitive advantage against other recreational edible brands. The Company believes tremendous opportunities currently exist to launch successful and legally compliant products in this space, and that such opportunities will continue to grow over time.

Management Team

Nightfood founder and CEO Sean Folkson is a formerly frustrated nighttime snacker whose late-night cravings led him to seek a better solution for himself and others through the creation, marketing and distribution of the Nightfood product line. Folkson also founded internet marketing company AffiliatePros.com which provided the startup capital to launch Specialty Equipment Direct, an online distributor of floor removal equipment that quickly grew to 7-figure revenues. Folkson received a bachelor’s degree in business administration with a concentration in marketing from S.U.N.Y Albany, New York, in 1991.

Jim Christensen, vice president of Nightfood Ice Cream, is the former Vice President of Ice Cream Sales with global ice cream giant Unilever. In his over 20 years at Unilever, Jim led sales and distribution initiatives for brands such as Ben & Jerry’s, Klondike, Breyers and Good Humor. Christensen joined the Nightfood team in June of 2018 with the directive to launch Nightfood ice cream rapidly into national distribution through supermarket, drug, convenience and other channels. Understanding that the overwhelming majority of at-home ice cream consumption occurs in the hours before bed, Christensen has identified Nightfood as the next evolution in better-for-you ice cream.

CFO Mark Noffke, CPA, has over 37 years of experience as a seasoned financial and management professional. He has served as chief financial officer of several small cap public companies since 2004 where he oversaw virtually every aspect of the company’s operations, administration, customer service and human resources. Noffke has a bachelor’s degree in accounting from Valparaiso University in Indiana.

Advisory Board

The Nightfood advisory board includes Tom Morse, founder of 5-Hour Energy and Living Essentials, LLC.; Doron Stern, former vice president of marketing at Chobani and Popcorn, Indiana; restaurateur and celebrity Chef Chris Santos; Paul Jarrett, CEO of fast-growing nutrition startup BuluBox; Eric Egeland, president of Capacity Consulting Inc.; Dr. Michael A. Grandner, director/Sleep and Health Research Program at the University of Arizona; Dr. Michael Breus, sleep expert and best-selling author known to millions as The Sleep Doctor(TM); Dr. Lauren Broch, resident nutrition, sleep disorder expert and a member of the scientific advisory board.

Nightfood Holdings, Inc. (NGTF), closed the day's trading session at $0.643, up 3.12%, on 364,079 volume with 81 trades. The average volume for the last 3 months is 555,749 and the stock's 52-week low/high is $0.16/$0.92.

Recent News

chart

Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF)

The QualityStocks Daily Newsletter would like to spotlight Choom Holdings Inc. (CHOOF).

British Columbia-based fully-integrated cannabis company Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) this morning announced that, on April 26,2019, the Alcohol and Gaming Commission of Ontario ("AGCO") issued a retail operator license to Lisa Bigioni and a retail store authorization for her Choom-branded cannabis store in Niagara Falls, Ontario. To view the full press release, visit http://nnw.fm/9XzLC. Also today, the company was featured in the 420 with CNW by CannabisNewsWire.

Choom Holdings Inc. (OTC: CHOOF) (CSE: CHOO) channels the laid-back spirit of Hawaii to the Okanagan region of British Columbia with a generous nod to the inspirational, yet unofficial, history of the 1970s "Choom Gang," a group of buddies in Honolulu (including former President Barack Obama) who knew how to relax with "choom," the local's term for marijuana. Choom's trademark slogans pivot off another unconventional phrase ("Say Hello to…"), bringing a heady dose of good times and good friends together as the company invites investors to "Say Hello to Choom™" as it lights up the adult recreational cannabis market in Canada.

Choom™ has been an ACMPR (Access to Cannabis for Medical Purposes Regulations) applicant since November 2013 in Vernon, B.C. The company's first application has received security clearance and is now in the detailed review stage. They also recently announced their second late-stage ACMPR application, which is in its confirmation of readiness stage. Cannabis Compliance Inc. has been retained to help expedite Choom's initial license applications to ensure the company's readiness for legalization of recreational marijuana in Canada mid-summer 2018.

True to the company's character, Choom™ is retrofitting two large facilities – No. 1 in Vernon, B.C., and No. 2 on Vancouver Island – to house its cannabis growing facilities. Phase 1 of the Vernon property will provide Choom™ with 6,800 square feet of growing space, capable of producing 660 kg/year of cannabis at an estimated revenue of $6.6 million, excluding oils. The company expects this facility to be completed by July 2018, the same month that Canada is expected to formally legalize recreational marijuana for adult use. A potential Phase 2, to be completed by the end of 2018, would add another 6,800 square feet for a total of 1,500 kg/year capacity, which would nearly double No. 1's revenue. A Level 9 vault is also planned with a storage capacity of 15,000 kg. While the No. 2 facility on Vancouver Island is smaller – 4,500 square feet – its retrofit is also slated to be completed by July 2018. Plans include doubling this space as well, which would add about $9 million in annual revenue, excluding cannabis oils.

Choom™ announced its retail dispensary strategy with the intention of establishing market leadership in reaching the Canadian cannabis consumer. The partner program is already in the retail space design stage as the company seeks to build a chain of branded retail cannabis dispensaries in jurisdictions in Canada where recreational cannabis is legal. Choom™ Stores will have a cool, modern layout and design created to emit an authentic "Aloha" vibe. Choom™ is all about producing high-grade cultivars and curating them for a bigger audience.

A savvy, experienced management team includes Chris Bogart, president and CEO; John Oh, R.P.I.C., Operations Manager; Robert Bayrack, Master Grower, S.P.I.C.; and Adrian Robinson, Strategic Advisor. Bogart has over two decades of international experience in capital markets and was a co-founder of InMed Pharmaceuticals and Magnum Uranium. He has structured complex equity financing transactions in the U.S., Europe and Canada. Bogart is joined on the Board of Directors by Kevin Pull, Stephen Tong and John Oh.

While the medical marijuana industry is expected to double by 2021 to 500,000 registered users, the true highlight of the recreational cannabis represents the key cultural shift set to launch in Canada. With an estimated $4.9B to $8.7B retail market coming, now is the right time for a Recreation Brand like Choom™ to be involved in this growing industry. Establishing and maintaining Choom™ premium brand loyalty is a key factor in the company's growth strategy. Get ready to "Say Hello" to opportunity, good times and good friends with Choom™.

Choom Holdings Inc. (CHOOF), closed the day's trading session at $0.455, up 1.11%, on 425,397 volume with 222 trades. The average volume for the last 3 months is 620,126 and the stock's 52-week low/high is $0.285/$1.129.

Recent News

chart

Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (FF: O3X4)

The QualityStocks Daily Newsletter would like to spotlight Redfund Capital Corp. (PNNRF).

Enterprising Canadian finance firm Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) is strengthening its business incubation model through equity financing and debt financing in the emerging cannabis industries, announcing recently that it will partner with the Cannabis Mercantile Exchange ("Cannamerx") as Cannamerx rolls out the first international global hemp and cannabidiol (CBD) auction platform. NOTE TO INVESTORS: The latest news and updates relating to PNNRF are available in the company's newsroom at http://nnw.fm/PNNRF.

Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (FF: O3X4) is a merchant bank focused on providing debt and equity funding in the mid to late stages of a target company’s development and for technologies that are developed and validated by revenues. Redfund’s current focus is on medical cannabis, hemp and cannabidiol (CBD) related and healthcare-related companies.

As the first medical cannabis incubator and accelerator financing medical cannabis, CBD and hemp companies through a debt facility, Redfund is effectively bridging finance gaps and helping revenue-producing medical cannabis-related companies grow and build their valuations without prematurely diluting their equity.

The central components of the company’s business strategy are:

  • Establishing the foundation of a loan portfolio that generates revenues through monthly interest income from loans to cover all general and administrative expenses related to day-to-day operations.
  • Growing shareholder value by converting all or part of loans and warrants into equity in portfolio clients as clients build their valuations by entering the public markets or becoming the high-priced targets of larger entities.

Redfund was designed by bankers and entrepreneurs possessing years of experience in business, consulting, capital markets, corporate finance and healthcare services. The company is actively looking beyond borders and creating global companies that have strong fundamentals and are ready to expand.

Redfund’s investments are deployed to companies that have demonstrated success in their business but need a capital bridge in order to expand. Redfund’s team of professionals vet every project and analyzes each prospective client’s financials and business plans. Once a project is approved, Redfund’s legal team carefully scrutinizes the collateral used to securitize the individual loans.

The strategy employed by Redfund includes:

  • Diversifying investments in Canada and other countries
  • Building an international footprint with established national leaders
  • Funding new drug delivery systems and helping nutraceuticals become mainstream drugs
  • Introducing companies to Canada as a viable option for public listings
  • Becoming a premier go-to lender for established companies

The company’s revenue sources include:

  • Interest-bearing debt instruments with asset-backed collateral to securitize loans
  • Equity kicker of warrants coverage on original loan
  • Conversion ability of loan in its entirety
  • Advisory fees from contracts for consulting on growth strategies
  • Right of first refusal on future financing in each company funded

Redfund Capital Corp. (PNNRF), closed the day's trading session at $0.131, even for the day, on 5,000 volume. The average volume for the last 3 months is 503 and the stock's 52-week low/high is $0.10/$0.505.

Recent News

chart

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

Plus Products Inc. (CSE: PLUS) (OTCQB:PLPRF), announces that it has elected to accelerate the expiry of the certain warrants of the Company's wholly-owned subsidiary, Plus Products Holdings Inc. ("PPH"), which were assumed and honored by the Company pursuant to the Share Exchange Agreement between the Company and PPH, dated July 3, 2018, and which closed on July 24, 2018.

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed the day's trading session at $3.40, off by 4.35%, on 144,783 volume with 243 trades. The average volume for the last 3 months is 85,866 and the stock's 52-week low/high is $0.10/$0.505.

Recent News

chart

Cannabis Strategic Ventures, Inc. (NUGS)

The QualityStocks Daily Newsletter would like to spotlight Cannabis Strategic Ventures, Inc. (NUGS).

Los Angeles, California-based cannabis firm Cannabis Strategic Ventures (OTC: NUGS), through its diverse portfolio of subsidiaries, is focused on supporting entrepreneurial growth within the cannabis sector. To view the full article, visit: http://nnw.fm/p4Uig.

Cannabis Strategic Ventures, Inc. (NUGS), headquartered in Los Angeles, California, is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. Through a selective portfolio of subsidiaries, Cannabis Strategic Ventures offers outsourced personnel solutions tailor-made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries and other cannabis marketplace participants. The company also pursues investment opportunities in the areas of real estate, cultivation, extraction, distribution, packaging, dispensary operations, and branded products within the cannabis space.

The legalization of adult-use sales in California is expected to create nearly 99,000 cannabis industry jobs in the state by 2021, representing about a third of all cannabis jobs nationwide, and 146,000 jobs overall when indirect and induced efforts are considered, according to Arcview Market Research. By 2021, direct cannabis industry employment will top 291,500 FTE jobs, with a total employment effect of nearly 414,000 FTEs across all legal cannabis states, according to the report.

Cannabis Strategic Ventures believes its staffing capabilities will be in a similar state of demand. The company in April 2018 completed a definitive agreement to acquire Worldwide Staffing Group, Inc., which booked approximately $1.5 million in revenues in 2017.

Worldwide will operate within Cannabis Strategic Ventures as an independent and separate wholly owned subsidiary providing strictly non-cannabis related employment and staffing services. As Worldwide continues to expand its operations in general clerical and administrative, marketing, accounting, and other verticals, Cannabis Strategic Ventures will leverage the subsidiary’s expertise to expand its business operations further into the cannabis staffing arena, with an emphasis on the California markets.

Cannabis Strategic Ventures’ BudHire™ subsidiary is an outsourced employment service specifically designed to meet the needs of growing cannabis-related business operations, utilizes a proven recruiting formula to match the most qualified candidates to a broad spectrum of cannabis-related jobs. Under the BudHire™ brand, Cannabis Strategic Ventures offers temporary, seasonal, permanent staffing solutions, as well as professional employment organization services and human resources consulting to the cannabis industry.

Cannabis Strategic Ventures portfolio also includes Pure Applied Sciences Inc. and its brand “PureOrganix™,” a line of high quality concentrate, organic and pure cannabis oils that conform with Current Good Manufacturing Practices (cGMP) and meet FDA guidelines for Active Pharmaceuticals Products (API). The acquisition includes all intellectual properties, including formulations and technologies, and related accessories of Pure Applied Sciences.

Cannabis Strategic Ventures Pure Applied Sciences subsidiary, has a cannabis concentrate extraction services agreement with CP Logistics LLC (“CPL”), a wholly owned U.S. subsidiary of Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF). Under this agreement, CPL will perform white label services producing high quality, ultra-purified cannabis extracts out of its Sun-Oil Facility in Cathedral City, California, for Pure Applied Sciences under the Pure Organix brand name.

The management team at Cannabis Strategic Ventures believes there is incredible opportunity to carve-out and control specific industry niches, to create unique cannabis consumer branded products, and to expand into other sub-sectors of the cannabis marketplace.

Cannabis Strategic Ventures, Inc. (NUGS), closed the day's trading session at $1.13, off by 8.13%, on 152,272 volume with 289 trades. The average volume for the last 3 months is 97,051 and the stock's 52-week low/high is $0.75/$5.94.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Biotechnology company and drug-delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has developed and out-licenses its pioneering-drug delivery platform DehydraTECH(TM), which improves the speed, taste and delivery of bioactive compounds, including nicotine and cannabinoids. To view the full article, visit: http://nnw.fm/bSL9u.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECHTM technology to improve taste, remove odor, and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada, the largest-market states in the United States, and internationally. Lexaria has entered into a R&D partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea, and supplements. These brands include ViPova™ and TurboCBD™.

In 2015, Lexaria commissioned an independent third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation improve intestinal absorption as much as 500%. Lexaria has conducted multiple rounds of studies including in vivo and human clinical. In absorption studies conducted on rats, for example, Lexaria detected nicotine in the animal’s bloodstream just two minutes after it entered the stomach. In a randomized, double blinded human clinical study, cannabidiol (CBD) was measure in the human bloodstream at a 317% higher rate 30 minutes after swallowing a capsule processed with DehydraTECH than a non-enhanced capsule of equal strength.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: Hemp/CBD; Pharmaceutical; Cannabis; and Nicotine.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the end of 2018, the company’s patent portfolio includes 53 patent applications filed and pending in more than 40 countries around the world; and 10 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally in 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third-partners and has signed royalty deals with start-up companies as well as with a Fortune 100. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $1.07, off by 0.93%, on 119,634 volume with 95 trades. The average volume for the last 3 months is 132,125 and the stock's 52-week low/high is $0.75/$2.43.

Recent News

chart

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)

The QualityStocks Daily Newsletter would like to spotlight Wildflower Brands Inc. (WLDFF).

The recently announced LOI (http://nnw.fm/uGJ04) for the acquisition of Vancouver-based licensed cannabis retailer City Cannabis Corp. by wellness brand builder Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) is a major step for Wildflower.

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) is a public cannabis company developing and designing brands that focus on plant-based wellness and health products. Wildflower markets its full-spectrum CBD products to retailers in the health and wellness space throughout the United States and in legal cannabis markets in accordance with regulations marketing its THC and CBD products.

Headquartered in Vancouver, British Columbia, Canada, Wildflower employs a unique and holistic business model that encompasses research and development, manufacturing, distribution, marketing and retail. First launched in 2012 as a private company with a cannabis-focused brand, Wildflower went public in 2014 and has since reached numerous significant milestones in its drive to create brands that work in synergy toward becoming a global wellness brand leader.

Gathered within the growing family of Wildflower brands are the following entities:

  • Wildflower Wellness is known for its reputable brand, uncompromising quality and mission to connect people with the healing power of plants. Wildflower Wellness offers CBD vaporizers, capsules, tinctures, soaps and topicals that are backed by a 100 percent satisfaction guarantee. Wildflower Wellness offers a full lineup of full spectrum CBD extract infused products made in the U.S. in Wildflower’s GMP facilities which are always third-party lab tested for quality assurance and accurate labeling.
  • King Extracts is a California-based company focused on cannabis technology and delivery systems. The King Recharge is a discreet, 97mm small, rechargeable vaporizer with a sleek pocket-sized charging and storage case. King concentrates are clean and sophisticated blends made from CO2 extractions that are fractionally distilled for clarity and purity with proprietary terpenes blended in to deliver a robust, full-flavor profile. King products are available at 26 select, regulated retail dispensaries in California.
  • Exclusive is a dispensary of high-quality cannabis products and accessories serving the city of Los Angeles, California. The company enjoys a close association with select hospital oncology departments and community programs.

Using the slogan “Plants Heal,” Wildflower’s distribution network in the U.S. includes 200+ retailers in Washington state and 20+ retailers in New York City. Wildflower has also partnered with Retail Worx to establish shop-in-shop retail locations in the heart of New York City which pairs nicely with the introduction of Wildflower into existing Bridges General’s stores in New York City and San Francisco. Through this partnership with Retail Worx, Wildflower by Bridges General stores will have exclusive product offerings in addition to the full lineup of existing Wildflower Wellness CBD products. Distribution in other U.S. markets includes 80+ wellness and healthcare practitioners with a total distribution of over 300 stores nationwide.

Wildflower holds 14 California cannabis licenses that cover recreational and medical cannabis cultivation, manufacturing, distribution and retail/delivery in the jurisdictions of California state and the city of Los Angeles. Opportunities to activate these licenses creates the phenomenal potential of driving significant revenues while minimizing risk. Expansion plans into Canada are underway with discussions centered on retail acquisitions and Wildflower launching into over-the-counter market with its CBD product line. Global expansion is a key part of Wildflower’s strategy with initial plans aimed at specific international markets where regulatory hurdles are less restrictive.

In December 2018, Wildflower began on-demand, legal and licensed cannabis delivery services to adult consumers in the Los Angeles area and has hired dozens of full-time delivery drivers to accommodate this unmet need. Wildflower has partnered with leading technology and logistics company Eaze.com to help route deliveries efficiently, manage inventory and comply with California law. Providing legal, licensed delivery services helps to ensure that all adults including those with mobility challenges and limited access to transportation services can purchase high quality, legal cannabis products.

Wildflower’s direct-to-consumer online store sales have shown an organic growth. The Company recently achieved over 300 percent growth in online sales since January 2018 with annualized revenues exceeding $1 million for online sales only, marking the ninth consecutive quarter of increased revenue.

Core Team

William MacLean is the founder and CEO of Wildflower Brands Inc. His involvement in all aspects of the business from product R&D to manufacturing setup has led the Company to its current success. MacLean is a seasoned sales professional with over 20 years of experience in various industries from advertising and marketing to medical sales. While in the advertising and marketing space, his clients included major brands including: Bell, Remax, BC Hydro, and Royal Bank.

CFO Stephen Pearce is a director and officer of a number of public companies in the resource sector. His professional experience as a practicing attorney is primarily in corporate and securities work. Pearce’s academic background includes an honors bachelor’s degree in economics from York University, in which he focused specifically on corporate finance. Pearce obtained a law degree from the University of British Columbia.

Alfred Kee, COO, is a business technology leader with over 15 years of experience in building high performing teams at small startups to large enterprises. With foundations in running large scale business critical technology and user experience product management mindset, Kee excels at guiding teams to deliver business value with agility. His knowledge and experience were honed while working with Electronic Arts, KPMG, CenturyLink, Cisco and Apple, as well as a string of successful startups. Lee brings a global perspective having lived and worked through parts of the U.S., Canada, Europe and Asia.

Creative Director Amy Yamamura is a founding member of Wildflower and has been a driving force behind the Company from the start, creating the Wildflower brand. After receiving a bachelor’s degree in communications from Boston University, Yamamura returned to Tokyo to develop her career in TV as an international business correspondent coordinating collaborative projects between top creators around the world and corporations. Yamamura’s unique experience in working closely with successful Japanese brands like UNIQLO has given her exceptional eyes for branding a company.

Wildflower Brands Inc. (WLDFF), closed the day's trading session at $0.5461, off by 2.41%, on 19,260 volume with 21 trades. The average volume for the last 3 months is 22,774 and the stock's 52-week low/high is $0.009/$1.139.

Recent News

chart

Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF)

The QualityStocks Daily Newsletter would like to spotlight Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF).

Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF) this morning announced its entry into a funding agreement with The Physician's Choice CBD LLC ("PCCBD") of Phoenix, Arizona, which is dedicated to researching, developing and utilizing the highest quality of hemp-derived cannabidiol ("CBD") in combination with well-studied and effective supplements to assist in supporting and regulating various symptoms. To view the full press release, visit http://nnw.fm/C1cfU.

Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF), an investment company focused on the U.S. and international cannabis sectors, provides turnkey solutions for the regulated cannabis industry. The company leverages managements' expertise and decades of experience in the cannabis industry to acquire and develop vertically integrated cannabis assets. Chemistree recently closed on a purchase of prospective cannabis cultivation property in California, made a first investment in the Canadian cannabis industry, owns assets in the State of Washington used to operate an established retail cannabis brand, and has an active pipeline of assets in place to grow its portfolio.

Chemistree offers industry leading expertise across all areas the cannabis business and in its growth as a public or private company.

  • Investment and funding for rapid growth
  • Vertical integration solutions
  • Construction, design and/or optimization of indoor or outdoor cultivation facilities
  • Reputation management & influencer outreach
  • Branding and Packaging
  • Social Media and Media outreach

With the marketing of cannabis companies and their products in its infancy, the company believes the industry offers tremendous opportunity for growth in the U.S. and abroad. Chemistree initially targeted the Pacific Northwest for investment and, following its recent California property purchase, expects to expand vertically across the United States in areas where it has a competitive business advantage.

Through its wholly owned CHM Desert LLC subsidiary, Chemistree owns 9.55 acres of undeveloped land in Desert Hot Springs, California. The property is zoned as Light Industrial Lands Designated for Marijuana Cultivation, and local zoning ordinances allow as a conditional use the location of up to three onsite cannabis cultivation buildings of 68,000 square feet each, along with support space that would support production of 55,000 pounds/year.

Through its wholly owned Chemistree Washington Ltd. subsidiary, Chemistree acquired physical assets used in the cultivation, production and distribution of cannabis. The Washington assets are currently under lease to Sugarleaf Farm LLC, which operates the Sugarleaf brand of retail cannabis products in the State of Washington. Sugarleaf Farm is a Tier 3 cannabis producer and processor whose products are sold in about 125 retail outlets. Chemistree has indicated the relationship with Sugarleaf may provide the company with additional opportunities to become involved in the marketing of Sugarleaf products.

Chemistree funded these acquisitions and investments with the proceeds of two non-brokered private placement financings completed earlier this year under the regulations of the Canadian Securities Exchange, totaling CAD$4.5 million. In conjunction with the private placements, the company was granted approval by the CSE for a change of business to become an Investment Issuer. This funding is expected to provide the company "maximum flexibility to take advantage of the numerous opportunities available in the cannabis industry in Canada and the U.S."

Chemistree also has a strategic investment in Pasha Brands Ltd., a British Columbia based cannabis company with multiple internationally recognized brands. Pasha has a proven history in cannabis retailing and its proposed Licensed Processing (LP) facility on Vancouver Island is in the final stage of the application for government approval. The LP facility is expected to assist in licensing selected craft growers of cannabis and expanding the distribution of locally grown product. The investment represents less than 10% of Chemistree's working capital.

Company Chairman Justin Chorbajian is co-owner of the largest chain of privately owned hydroponic retail shops in Canada. He also cofounded a group of companies that manufacture and distribute hydroponic equipment. He is a frequent contributor to Growing Exposed, the leading video series dedicated to cannabis cultivation. Company President Karl Kottmeier is a former investment advisor with 20 years of experience listing, financing and administering companies on the Toronto Stock Exchange and TSX Venture Exchange. He has raised more than $150 million in equity capital for ventures. Chemistree CFO Doug Ford has been general manager of Dockside Capital Group Inc., a private merchant banking and venture capital firm serving emerging growth companies. Sheldon Aberman, the most recent member of the Board, has managed, designed and created industry leading grow room designs around the world. Additionally, he has built several leading brands such as Frost Box and Black Label and is an expert in the accessory market (vape pens, silicon mats and extraction tools etc.).

Data firm Statista has forecast the U.S. legal cannabis market will be worth more than $24 billion by 2025. New Frontier Data, which focuses exclusively on the cannabis industry, projects the value of the Canadian domestic cannabis market that same year at CAD$9.2 billion.

Chemistree Technology Inc. (CHMJF), closed the day's trading session at $0.494, off by 0.91%, on 185,937 volume with 131 trades. The average volume for the last 3 months is 60,090 and the stock's 52-week low/high is $0.268/$0.605.

Recent News

chart

Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Earth Science Tech (OTCQB: ETST) boasts a suite of offerings that are derived from hemp rather than marijuana, making them compliant with the 2018 Farm Bill. This key difference results in a significant edge over competitors by permitting ETST to legally ship its Full Spectrum CBD products to all 50 states. To view the full article, visit: http://nnw.fm/PK9Vg.

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed the day's trading session at $0.49199, off by 18.00%, on 94,464 volume with 44 trades. The average volume for the last 3 months is 33,314 and the stock's 52-week low/high is $0.421/$2.45.

Recent News

chart

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

ChineseInvestors.com, Inc. (OTCQB: CIIX), an established financial news and investment portal, and a leading industrial hemp/CBD retailer to the global Chinese-speaking community, today announced that its wholly owned subsidiary, ChineseHempOil.com, Inc. dba Chinese Wellness Center ("CWC") will launch a pop-up kiosk in the Glendale Galleria mall, located in Glendale, California, beginning May 1, 2019. The pop-up kiosk will carry various industrial hemp/CBD products, including CWC's own OptHemp product line. For more information, please visit www.365cwc.com..

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed the day's trading session at $0.47745, off by 4.51%, on 24,378 volume with 31 trades. The average volume for the last 3 months is 72,830 and the stock's 52-week low/high is $0.365/$1.25.

Recent News

chart

Pacific Software, Inc. (PFSF)

The QualityStocks Daily Newsletter would like to spotlight Pacific Software, Inc. (PFSF).

Pacific Software, Inc. (PFSF) is an emerging technology corporation positioned for investments, mergers and acquisitions of software technologies and platforms. The company is building “BoaPin,” a subscription-based e-commerce trading platform focused on cross border trade expansion with an international emphasis. The multi-faceted e-commerce platform is scheduled for launch in Q1 of 2019.

The Company is uniquely positioned to deliver a B2B and B2C intelligent e-commerce trade platform which will provide various solutions, data, applications and tools for subscribers, including IBM’s Hyperledger Blockchain “Backend as a Service” (BaaS) Infrastructure, multi-lingual communication, fintech, digital marketing, smart contracts, commodities search/match applications, customs clearance, taxation data, product advertising and logistics solutions.

Through smart contract technology for global supply chain management, BoaPin is designed to improve product traceability and deliver solutions to its subscribers for product certification, marketing, logistics, commodities search/match interface, trade finance, cross border payment solutions and customs clearance. Some of the tools available to execute these capabilities include cross border payments, blockchain solutions, smart contracts and multilingual access.

With these features at hand, the company is targeting several key industries where its online applications and solutions could have significant corporate impact in various forms, including: agriculture, fertilizers, chemicals, cosmetics, electronics, equipment, apparel and controlled substance management.

Business Model

Pacific Software initially will focus on Brazil and China for BoaPin. After paying a registration fee to utilize the online trade portal, subscribers to the platform will have access to a variety of tools and features that may enhance and increase revenue initiatives by showcasing their commodities and products for sale or trade.

Buyers of the commodities, products or services will pay a transaction fee only to the company which could materialize in the form of cash, cash equivalents, royalties or in-kind fees.

As the company executes its strategy, the online trade business is anticipated to generate significant revenue from subscribers obtained from regionally and federally organized Brazilian Trade Associations. The members wish to market their commodities or products, and the portal users or buyers materialize from China, Hong Kong and surrounding countries. As a result, this business model may be organized separately in the company’s wholly owned subsidiary, incorporated as HyperSoft Ventures, which could generate appreciable value for investors and shareholders.

Pacific Software, Inc. (PFSF), closed the day's trading session at $4.50, even for the day. The stock's 52-week low/high is $2.0/$5.50.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.